Safety of RG2077 in Patients With Multiple Sclerosis

This study has been completed.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Multiple Sclerosis, Relapsing-Remitting
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Interventions listed in this trial
			RG2077 (CTLA4-IgG4m)
5		Sponsors listed in this trial
			National Institute of Allergy and Infectious Diseases (NIAID)
			Immune Tolerance Network